MindMed Announces Launch of Collaboration with Nextage Therapeutics' Brain Targeting Liposome System Home > Business > Article
3 years ago By Victor — NEW YORK, May 24, 2021 /CNW/ -- MindMed (NASDAQ: MNMD, NEO: MMED, DE: MMQ), a leading clinical stage psychedelic medicine company, and Nextage Therapeutics
#mindmedannounceslaunch #collaboration #nextagetherapeutics